229 related articles for article (PubMed ID: 38695938)
1. The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review.
van Maaren MC; van Hoeve JC; Korevaar JC; van Hezewijk M; Siemerink EJM; Zeillemaker AM; Klaassen-Dekker A; van Uden DJP; Volders JH; Drossaert CHC; Siesling S;
Support Care Cancer; 2024 May; 32(5):323. PubMed ID: 38695938
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.
Klaassen-Dekker A; Drossaert CHC; Van Maaren MC; Van Leeuwen-Stok AE; Retel VP; Korevaar JC; Siesling S;
BMC Cancer; 2023 Nov; 23(1):1112. PubMed ID: 37964214
[TBL] [Abstract][Full Text] [Related]
4. Opportunities for personalised follow-up care among patients with breast cancer: A scoping review to identify preference-sensitive decisions.
de Ligt KM; van Egdom LSE; Koppert LB; Siesling S; van Til JA
Eur J Cancer Care (Engl); 2019 May; 28(3):e13092. PubMed ID: 31074162
[TBL] [Abstract][Full Text] [Related]
5. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
7. Systematic screening and assessment of psychosocial well-being and care needs of people with cancer.
Schouten B; Avau B; Bekkering GTE; Vankrunkelsven P; Mebis J; Hellings J; Van Hecke A
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012387. PubMed ID: 30909317
[TBL] [Abstract][Full Text] [Related]
8. Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.
Vale L; Kunonga P; Coughlan D; Kontogiannis V; Astin M; Beyer F; Richmond C; Wilson D; Bajwa D; Javanbakht M; Bryant A; Akor W; Craig D; Lovat P; Labus M; Nasr B; Cunliffe T; Hinde H; Shawgi M; Saleh D; Royle P; Steward P; Lucas R; Ellis R
Health Technol Assess; 2021 Nov; 25(64):1-178. PubMed ID: 34792018
[TBL] [Abstract][Full Text] [Related]
9. Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy.
Stuiver MM; ten Tusscher MR; Agasi-Idenburg CS; Lucas C; Aaronson NK; Bossuyt PM
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD009765. PubMed ID: 25677413
[TBL] [Abstract][Full Text] [Related]
10. Trial of Optimal Personalised Care After Treatment-Gynaecological Cancer (TOPCAT-G): A Randomized Feasibility Trial.
Morrison V; Spencer LH; Totton N; Pye K; Yeo ST; Butterworth C; Hall L; Whitaker R; Edwards RT; Timmis LJ; Hoare Z; Neal RD; Wilkinson C; Leeson S
Int J Gynecol Cancer; 2018 Feb; 28(2):401-411. PubMed ID: 29324539
[TBL] [Abstract][Full Text] [Related]
11. Interventions for promoting habitual exercise in people living with and beyond cancer.
Turner RR; Steed L; Quirk H; Greasley RU; Saxton JM; Taylor SJ; Rosario DJ; Thaha MA; Bourke L
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD010192. PubMed ID: 30229557
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness Analysis of an Aftercare Service vs Treatment-As-Usual for Patients with Severe Mental Disorders.
Barfar E; Sharifi V; Amini H; Mottaghipour Y; Yunesian M; Tehranidoost M; Sobhebidari P; Rashidian A
J Ment Health Policy Econ; 2017 Sep; 20(3):101-110. PubMed ID: 28869209
[TBL] [Abstract][Full Text] [Related]
13. A text message intervention to support women's physical and mental health after breast cancer treatments (EMPOWER-SMS): a randomised controlled trial protocol.
Singleton A; Partridge SR; Raeside R; Regimbal M; Hyun KK; Chow CK; Sherman K; Elder E; Redfern J
BMC Cancer; 2019 Jul; 19(1):660. PubMed ID: 31272399
[TBL] [Abstract][Full Text] [Related]
14. Follow-up after breast cancer: Variations, best practices, and opportunities for improvement according to health care professionals.
Ankersmid JW; van Hoeve JC; Strobbe LJA; van Riet YEA; van Uden-Kraan CF; Siesling S; Drossaert CHC;
Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13505. PubMed ID: 34449103
[TBL] [Abstract][Full Text] [Related]
15. Internet- and mobile-based aftercare and follow-up for mental disorders: protocol of a systematic review and meta-analysis.
Hennemann S; Farnsteiner S; Sander L
BMJ Open; 2017 Jun; 7(6):e016696. PubMed ID: 28652294
[TBL] [Abstract][Full Text] [Related]
16. Towards a personalised approach to aftercare: a review of cancer follow-up in the UK.
Davies NJ; Batehup L
J Cancer Surviv; 2011 Jun; 5(2):142-51. PubMed ID: 21253881
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness and cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs: a systematic review and economic evaluation.
Hayhurst KP; Leitner M; Davies L; Flentje R; Millar T; Jones A; King C; Donmall M; Farrell M; Fazel S; Harris R; Hickman M; Lennox C; Mayet S; Senior J; Shaw J
Health Technol Assess; 2015 Jan; 19(6):1-168, vii-viii. PubMed ID: 25619533
[TBL] [Abstract][Full Text] [Related]
18. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
19. Personalised risk communication for informed decision making about taking screening tests.
Edwards AG; Naik G; Ahmed H; Elwyn GJ; Pickles T; Hood K; Playle R
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD001865. PubMed ID: 23450534
[TBL] [Abstract][Full Text] [Related]
20. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
